| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/27/2002 | WO2002050028A2 Substituted benzoindoles as spla2 inhibitors |
| 06/27/2002 | WO2002050021A1 Nitric oxide synthase inhibitor phosphate salt |
| 06/27/2002 | WO2002050019A2 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | WO2002049993A2 High affinity small molecule c5a receptor modulators |
| 06/27/2002 | WO2002049656A1 External skin preparations and process for producing the same |
| 06/27/2002 | WO2002049642A2 Use of 5-hydroxy and 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acids and their esters as agents useful for healing skin lesions and stimulants of angiogenesis |
| 06/27/2002 | WO2002049634A2 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect |
| 06/27/2002 | WO2002049627A2 Antifungal compositions containing an antibiotic and one or more amidoamines |
| 06/27/2002 | WO2002049625A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | WO2002049605A2 Methods and compositions for protecting and restoring skin using selective mmp inhibitors |
| 06/27/2002 | WO2002049603A1 Compositions for prevention and alleviation of skin wrinkles |
| 06/27/2002 | WO2002049599A2 Filtering composition containing a 1,3,5-triazine derivative, a dibenzoylmethane derivative, and a 4,4-diarylbutadiene compound |
| 06/27/2002 | WO2002049593A2 Use of dna repair enzymes as mmp-1 inhibitors |
| 06/27/2002 | WO2002049580A1 Compositions and methods for treating hyperpigmentation |
| 06/27/2002 | WO2002034232A3 Use of carotenoids for treating ageing symptoms |
| 06/27/2002 | WO2002034231A3 Use of the association of at least an plant extract of genus rosmarinus and of at least a carotenoid |
| 06/27/2002 | WO2002030879A3 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 06/27/2002 | WO2002030353A3 NF-λB INHIBITORS |
| 06/27/2002 | WO2002026935A3 TGF-β INHIBITORS AND METHODS |
| 06/27/2002 | WO2002024613A3 Resorcinol derivatives |
| 06/27/2002 | WO2002022602A3 Triazole compounds useful as protein kinase inhibitors |
| 06/27/2002 | WO2002020566A3 NOVEL MMP-2 DERIVATIVES FOR USE AS INHIBITORS OF INTEGRIN αVβ¿3? |
| 06/27/2002 | WO2002006821A3 Antimicrobial agent |
| 06/27/2002 | WO2001096298A3 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
| 06/27/2002 | WO2001094381A3 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 06/27/2002 | WO2001076600A3 Inhibition of cytokine generation |
| 06/27/2002 | WO2001073025A3 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 06/27/2002 | WO2001070978A3 Polypeptides and nucleic acids encoding same |
| 06/27/2002 | WO2001051051A3 Agents, such as nicotinamide or cadpr for the treatment of skin disorders |
| 06/27/2002 | WO2000056350A9 Methods of use of beta 1-integrin inhibitors |
| 06/27/2002 | WO2000056345A9 Methods for limiting scar and adhesion formation |
| 06/27/2002 | US20020082420 Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them |
| 06/27/2002 | US20020082419 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 06/27/2002 | US20020082388 Polypeptide for use in the treatment, diagnosis and prevention of cancer, nervous system and developmental disorders |
| 06/27/2002 | US20020082292 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma |
| 06/27/2002 | US20020082279 Topical mixture of a carrier, essential oil, and a conventional dermatologic active ingredient |
| 06/27/2002 | US20020082266 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore |
| 06/27/2002 | US20020082265 For treating or preventing emphysema, cancer and dermatological disorders |
| 06/27/2002 | US20020082256 Compounds useful as anti-inflammatory agents |
| 06/27/2002 | US20020082255 Substituted ureas |
| 06/27/2002 | US20020082251 Desmethylolanzapine compositions and methods |
| 06/27/2002 | US20020082250 Beta lactams as antiproliferative agents |
| 06/27/2002 | US20020082246 Prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved; these include degenerative joint disorders such as osteoarthroses and disorders of connective tissue |
| 06/27/2002 | US20020082231 Utilizing ratC polypeptides to screen for antibacterial compounds |
| 06/27/2002 | US20020082226 Antisense antibacterial method and composition |
| 06/27/2002 | US20020082222 Treatments for neurogenetic disorders, impulse control disorder, and wound healing |
| 06/27/2002 | US20020082221 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing S-N=O, N-N=O or |
| 06/27/2002 | US20020082205 Human FGF-23 gene and gene expression products |
| 06/27/2002 | US20020081659 Nucleic acids, proteins and antibodies |
| 06/27/2002 | US20020081623 Chemotactic cytokine |
| 06/27/2002 | US20020081296 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 06/27/2002 | US20020081290 Protein kinase homologs |
| 06/27/2002 | US20020081288 A polypeptide selected from the group consisting of a SOD-4 polypeptide (superoxide dimutase) having a preferred deduced amino acid sequence and fragments, analogs and derivatives encoded by a specific polynucleotide |
| 06/27/2002 | DE10131641A1 St. John's wort extracts having reduced chlorophyll and proanthocyanidin contents, useful as topical medicaments, e.g. for treating stomatitis, acne, viral infections or psoriasis |
| 06/27/2002 | DE10063433A1 Verwendung von DNA-Reparatur-Enzymen als MMP-1-Inhibitoren The use of DNA repair enzymes as MMP-1 inhibitors |
| 06/27/2002 | CA2436531A1 Isolation of purified tgf-.beta.1 and tgf-.beta.2 from bone tissue techsource patent |
| 06/27/2002 | CA2433018A1 Thiazolyl inhibitors of tec family tyrosine kinases |
| 06/27/2002 | CA2432908A1 Diamines as modulators of chemokine receptor activity |
| 06/27/2002 | CA2432879A1 Anti-allergic complex molecules |
| 06/27/2002 | CA2432531A1 Use of dna repair enzymes as mmp-1 inhibitors |
| 06/27/2002 | CA2432417A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors |
| 06/27/2002 | CA2432315A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | CA2432265A1 Methods and compositions for protecting and restoring skin using selective mmp inhibitors |
| 06/27/2002 | CA2432036A1 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | CA2431721A1 Tetracyclic derivatives as spla2 inhibitors |
| 06/27/2002 | CA2431028A1 Tetracyclic carbazole derivates and their use as spla2 inhibitors |
| 06/27/2002 | CA2431023A1 Substituted benzoindoles as spla2 inhibitors |
| 06/27/2002 | CA2430918A1 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 06/27/2002 | CA2430808A1 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases |
| 06/27/2002 | CA2430595A1 Dissociated glucocorticoid receptor antagonists for the treatment of glucocorticoid associated side-effect |
| 06/26/2002 | EP1217067A2 Connective tissue growth factor-2 |
| 06/26/2002 | EP1216986A2 Novel delta dicarbonyl compounds and methods for using same |
| 06/26/2002 | EP1216705A2 The use of growth factor modulation compounds substituted with three vicinal phosphorus containing radical in the manufacture of a medicament for tissue repair |
| 06/26/2002 | EP1216696A2 Method for reducing the appearance of dark circles under the eyes |
| 06/26/2002 | EP1216692A2 Use of chroman derivatives in cosmetic and dermatological preparations |
| 06/26/2002 | EP1216690A2 Cosmetic and dermatological sunscreen compositions containing asymmetrically substituted triazine derivatives and citric esters surfactants |
| 06/26/2002 | EP1216689A2 Cosmetic and dermatological sunscreen compositions containing phenylene-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulphonic acids and/or their salts and citric esters surfactants |
| 06/26/2002 | EP1216686A2 Gel-creams of the o/w emulsion type containing one or more ammonium acryloyl dimethyltaurate/vinyl pyrrolidone copolymers |
| 06/26/2002 | EP1216685A2 Personal care compositions |
| 06/26/2002 | EP1216247A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 06/26/2002 | EP1216241A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 06/26/2002 | EP1216238A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 06/26/2002 | EP1216234A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 06/26/2002 | EP1216232A1 Heterocyclic compounds and methods for modulating cxcr3 function |
| 06/26/2002 | EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 06/26/2002 | EP1216221A2 Rxr modulators with improved pharmacologic profile |
| 06/26/2002 | EP1216019A1 No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product |
| 06/26/2002 | EP0906114B1 Antipsoriatic compositions comprising an asphodelus extract, method of making, and method of using |
| 06/26/2002 | EP0906096B1 Use of hydroxyprolines for the manufacture of a medicament for inhibiting leukocyte invasion of tissues |
| 06/26/2002 | EP0822812B1 Topical treatment and prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines |
| 06/26/2002 | EP0693933B1 Methods and compositions for delaying or preventing the onset of autoimmune disease |
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |
| 06/26/2002 | CN1355807A Thiazoloindolinone compounds |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355702A Use of arylalkanoylpyridazines |
| 06/26/2002 | CN1355689A Methods for regulating condition of mammalian keratinous tissue |
| 06/26/2002 | CN1355686A Micropigment mixture |
| 06/26/2002 | CN1355041A Plaster for treaitng burn and its preparing process |
| 06/26/2002 | CN1355040A Exterior-applied medicine for treating beriberi and tinea pedis and its preparing process |
| 06/26/2002 | CN1355034A Dinsinfecting article for treating pointed condyloma dermatosis and its preparing process |